TABLE 3.
Treatment and Recovery of Children Presenting With Acute-Onset Unilateral Facial Palsy, 2013–2018a
| All, n = 306 | Bell’s Palsy, n = 209 | Lyme-Related FP, n = 82 | Other, n = 15 | P b | |
|---|---|---|---|---|---|
| Treatment | |||||
| Antibiotics (full course) | 116 (38) | 36 (17) | 78 (95) | 2 (13) | <.001 |
| Completed antibiotics despite negative Lyme test result | 31 (10) | 25 (12) | 5 (6) | 1 (7) | <.001 |
| Corticosteroid- any | 203 (66) | 159 (76) | 33 (40) | 11 (73) | <.001 |
| Corticosteroid- standard course | 162 (53) | 130 (62) | 26 (32) | 6 (40) | <.001 |
| Antivirals | 45 (15) | 39 (19) | 6 (7) | 0 (0) | .04 |
| Recoveryc | n = 240 | n = 155 | n = 73 | n = 12 | — |
| Ultimate full recovery | 238 (99) | 154 (99) | 73 (100) | 11 (92) | .012 |
| Corticosteroid, any | 153 (64) | 117 (76) | 28 (38) | 8 (72) | <.001 |
| Corticosteroid, standard course | 124 (52) | 96 (62) | 23 (32) | 5 (45) | <.001 |
—, not applicable.
Categorical variables are described using n (%).
P values to compare characteristics by FP etiology were calculated by using χ2 tests for categorical variables and the Kruskal-Wallis equality-of-populations rank test for continuous variables.
Patients with documented follow-up = n.